Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Jason D. Doles

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6830-708X; OpenAlex author ID A5026162365. Sources: funder_awards.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
1
Labs led
0
Collaborators
6
Papers, trials and grants by year

2017: 1 grant · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 2

  1. A TGF-β/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer. Last author DOI 10.1073/pnas.2215095120↗
  2. Anticachectic regulator analysis reveals Perp-dependent antitumorigenic properties of 3-methyladenine in pancreatic cancer. Last author DOI 10.1172/jci.insight.153842↗

Grants 1

  1. Metabolic Alterations Driving PDAC-associated Muscle Wasting AWARD pancan:2017-jason-doles-phd-metabolic-alterations-driving-pdac-assoc

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Paige C. Arneson‐Wissink · 2 shared papers, 2022–2023 · strength 0.33
  2. Aneesha Dasgupta · 2 shared papers, 2022–2023 · strength 0.33
  3. Aminah Jatoi · 1 shared paper, 2023 · strength 0.18
  4. Lizhi Zhang · 1 shared paper, 2022 · strength 0.14
  5. Martín E. Fernández-Zapico · 1 shared paper, 2022 · strength 0.14
  6. Gina Lynn Razidlo · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.